Paul D. Burgess - Net Worth and Insider Trading
Paul D. Burgess Net Worth
The estimated net worth of Paul D. Burgess is at least $983,725 dollars as of 2024-12-28. Paul D. Burgess is the See Remarks of Cerevel Therapeutics Holdings Inc and owns about 21,880 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $983,725. Paul D. Burgess is also the Secretary of Translate Bio Inc and owns about 0 shares of Translate Bio Inc (TBIO) stock worth over $0. Details can be seen in Paul D. Burgess's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul D. Burgess has not made any transactions after 2023-08-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul D. Burgess
Paul D. Burgess Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul D. Burgess owns 2 companies in total, including Translate Bio Inc (TBIO) , and Cerevel Therapeutics Holdings Inc (CERE) .
Click here to see the complete history of Paul D. Burgess’s form 4 insider trades.
Insider Ownership Summary of Paul D. Burgess
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBIO | Translate Bio Inc | 2021-09-14 | Chief Operating Officer & CLO & other: Secretary |
| CERE | Cerevel Therapeutics Holdings Inc | 2023-08-04 | See Remarks |
Paul D. Burgess Latest Holdings Summary
Paul D. Burgess currently owns a total of 2 stocks. Among these stocks, Paul D. Burgess owns 21,880 shares of Cerevel Therapeutics Holdings Inc (CERE) as of August 4, 2023, with a value of $983,725 and a weighting of 100%. Paul D. Burgess also owns 0 shares of Translate Bio Inc (TBIO) as of September 14, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Paul D. Burgess
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2023-08-04 | 21,880 | 44.96 | 983,725 |
| TBIO | Translate Bio Inc | 2021-09-14 | 0 | 37.36 | 0 |
Holding Weightings of Paul D. Burgess
Paul D. Burgess Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul D. Burgess has made a total of 1 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the acquisition of 21,880 shares on August 4, 2023, which cost Paul D. Burgess around $501,708.
According to the SEC Form 4 filings, Paul D. Burgess has made a total of 1 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Translate Bio Inc is the sale of 71,833 shares on September 14, 2021, which brought Paul D. Burgess around $3 Million.
Insider Trading History of Paul D. Burgess
- 1
Paul D. Burgess Trading Performance
GuruFocus tracks the stock performance after each of Paul D. Burgess's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul D. Burgess is 17.31%. GuruFocus also compares Paul D. Burgess's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul D. Burgess within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul D. Burgess's insider trading performs compared to the benchmark.
Performance of Paul D. Burgess
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.3 | | | | | |
| Relative Return to S&P 500(%) | 4.46 | | | | | |
Paul D. Burgess Ownership Network
Paul D. Burgess Owned Company Details
What does Translate Bio Inc do?
Who are the key executives at Translate Bio Inc?
Paul D. Burgess is the Chief Operating Officer & CLO & other: Secretary of Translate Bio Inc. Other key executives at Translate Bio Inc include director & Chief Executive Officer & other: President Renaud Ronald C Jr , 10 percent owner Shire Human Genetic Therapies, Inc. , and 10 percent owner Takeda Pharmaceutical Co Ltd .
Translate Bio Inc (TBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Translate Bio Inc Insider Transactions
Paul D. Burgess Mailing Address
Above is the net worth, insider trading, and ownership report for Paul D. Burgess. You might contact Paul D. Burgess via mailing address: C/o Translate Bio, Inc., 29 Hartwell Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
